Historical review: Cytokines as therapeutics and targets of therapeutics
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (4) , 201-209
- https://doi.org/10.1016/j.tips.2004.02.011
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- Tumour necrosis factor in synovial exudates.Annals of the Rheumatic Diseases, 1988
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- The Molecular Control of Blood Cell DevelopmentScience, 1987
- Monoclonal Antibodies as Structural Probes for Oligomeric Human Interferon-GammaJournal of Interferon Research, 1985
- Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.The Journal of Experimental Medicine, 1984